<DOC>
	<DOCNO>NCT02568293</DOCNO>
	<brief_summary>The purpose study compare balloon angioplasty plus SBCV balloon angioplasty alone treatment stenosis within femoropopliteal artery .</brief_summary>
	<brief_title>Angioplasty + SBCV vs. Angioplasty Alone Femoropopliteal Artery Stenosis</brief_title>
	<detailed_description>This first-in-human study evaluate safety effectiveness novel adjunctive therapy , SBCV , use balloon angioplasty compare balloon angioplasty plus control agent ( saline ) use treatment stenosis within femoropopliteal artery . Effectiveness measure late lumen loss 24 week post treatment evaluate independent , blind core lab .</detailed_description>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>Scheduled balloon angioplasty stenosis femoropopliteal lesion ( ) Rutherford Clinical Category 14 ( claudication critical limb ischemia ) Lesions â‰¥70 % stenosis visual estimate A patent inflow artery free significant lesion At least one patent native outflow artery ankle History haemorrhagic stroke within 3 month screen History myocardial infarction , thrombolysis angina within 2 week screen Renal failure chronic kidney disease Severe calcification render lesion undilatable</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>